First Hawaiian Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-22,259
Closed -$1.91M 533
2024
Q4
$1.91M Buy
22,259
+5,171
+30% +$559K 0.06% 238
2024
Q3
$2.03M Buy
17,088
+7,902
+86% +$1.05M 0.07% 234
2024
Q2
$1.31M Sell
9,186
-8,742
-49% -$1.16M 0.04% 310
2024
Q1
$2.3M Sell
17,928
-410
-2% -$48.8K 0.07% 213
2023
Q4
$1.9M Buy
18,338
+8,423
+85% +$833K 0.06% 240
2023
Q3
$902K Buy
9,915
+1,807
+22% +$159K 0.03% 402
2023
Q2
$656K Buy
8,108
+2,028
+33% +$166K 0.02% 500
2023
Q1
$484K Buy
6,080
+1,464
+32% +$104K 0.02% 599
2022
Q4
$312K Sell
4,616
-1,350
-23% -$79.1K 0.01% 689
2022
Q3
$297K Sell
5,966
-74
-1% -$3.96K 0.01% 673
2022
Q2
$336K Buy
6,040
+1,304
+28% +$72.4K 0.01% 684
2022
Q1
$263K Buy
4,736
+732
+18% +$37.6K 0.01% 800
2021
Q4
$224K Buy
+4,004
New +$217K 0.01% 856
2020
Q1
Sell
-30,792
Closed -$891K 833
2019
Q4
$891K Sell
30,792
-15,316
-33% -$424K 0.04% 294
2019
Q3
$1.19M Sell
46,108
-2,302
-5% -$58.2K 0.06% 229
2019
Q2
$1.24M Sell
48,410
-2,048
-4% -$50.6K 0.07% 210
2019
Q1
$1.32M Sell
50,458
-19,866
-28% -$488K 0.07% 203
2018
Q4
$1.62M Buy
70,324
+2,964
+4% +$65.9K 0.1% 145
2018
Q3
$1.59M Buy
+67,360
New +$1.64M 0.08% 181
2013
Q3
Sell
-4,690
Closed -$73K 403
2013
Q2
$73K Buy
+4,690
New +$78.1K 0.02% 305

Other funds holding NVO

First Hawaiian Bank's NVO Position: Q1 2025 in Review

First Hawaiian Bank sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 22,259 shares — an estimated $1.91M sold.

First Hawaiian Bank first reported a position in NVO in Q2 2013 and held it in 20 quarters. The position peaked at $2.3M in Q1 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • First Hawaiian Bank reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • First Hawaiian Bank sold 22,259 Novo Nordisk shares in Q1 2025, an estimated $1.91M.
  • First Hawaiian Bank first reported a position in Novo Nordisk in Q2 2013 and held it in 20 quarters.
  • First Hawaiian Bank's Novo Nordisk position peaked at $2.3M in Q1 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.